We are live on
!
Find out more
KCM
Kingdon Capital Management Portfolio holdings
AUM
$976M
1-Year Est. Return
66.76%
This Fund
S&P 500
This Quarter
Est. Return
+5.08%
1 Year Est. Return
+66.76%
3 Year Est. Return
+217.15%
5 Year Est. Return
+352.97%
10 Year Est. Return
+2,412.55%
AUM
$1.46B
AUM Growth
-$358M
(-20%)
Cap. Flow
-$201M
Cap. Flow
% of AUM
-13.76%
Top 10 Holdings %
Top 10 Hldgs %
34.7%
Holding
154
New
47
Increased
9
Reduced
33
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AABA
Altaba Inc
AABA
|
+$44.8M |
| 2 |
Coca-Cola Europacific Partners
CCEP
|
+$36.6M |
| 3 |
Alibaba
BABA
|
+$33.3M |
| 4 |
American International
AIG
|
+$31.3M |
| 5 |
Martin Marietta Materials
MLM
|
+$27.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adient
ADNT
|
+$65M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$43.7M |
| 3 |
CMA
Comerica
CMA
|
+$29.4M |
| 4 |
NBL
Noble Energy, Inc.
NBL
|
+$28M |
| 5 |
Tyson Foods
TSN
|
+$25.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.26% |
| 2 | Technology | 12.19% |
| 3 | Consumer Staples | 10.88% |
| 4 | Financials | 10.59% |
| 5 | Healthcare | 9.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Warrior Met Coal
HCC
$5.65B
| $9.58M | 0.65% |
+559,308
| New | +$9.72M |
|
52
Yum China
YUMC
$15.3B
| $9.42M | 0.64% |
+238,851
| New | +$8.62M |
|
53
Constellation Brands
STZ
$22.3B
| $9.09M | 0.62% |
+46,924
| New | +$8.35M |
|
54
CALL
Lexicon Pharmaceuticals
LXRX
$1.02B
| $8.21M | 0.56% |
+499,200
| New | +$7.73M |
|
55
Centene
CNC
$32B
| $8.15M | 0.56% |
+204,074
| New | +$7.7M |
|
56
Yum! Brands
YUM
$42B
| $7.88M | 0.54% |
+106,830
| New | +$7.43M |
|
|
ETFC
57
DELISTED
E*Trade Financial Corporation
ETFC
| $7.26M | 0.5% |
+190,873
| New | +$6.75M |
|
|
OTIC
58
CALL
DELISTED
Otonomy, Inc.
OTIC
| $7.06M | 0.48% |
+374,400
| New | +$5.22M |
|
|
CLVS
59
DELISTED
Clovis Oncology, Inc.
CLVS
| $7.01M | 0.48% |
+74,881
| New | +$4.58M |
|
|
PTLA
60
PUT
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $7.01M | 0.48% |
124,800
+74,800
| +150% | +$3M |
|
61
Wabtec
WAB
$49.4B
| $6.75M | 0.46% |
+73,800
| New | +$6.15M |
|
|
UPL
62
DELISTED
Ultra Petroleum Corp. Common Stock
UPL
| $6.51M | 0.45% |
+599,972
| New | +$6.77M |
|
|
OTIC
63
DELISTED
Otonomy, Inc.
OTIC
| $5.89M | 0.4% |
312,453
-461,240
| -60% | -$6.43M |
|
64
McDonald's
MCD
$188B
| $5.5M | 0.38% |
35,943
-14,057
| -28% | -$2.03M |
|
|
SGI
65
Somnigroup International
SGI
$13.5B
| $5.3M | 0.36% |
397,120
-620,520
| -61% | -$7.31M |
|
66
Mondelez International
MDLZ
$79.6B
| $5.21M | 0.36% |
+120,506
| New | +$5.43M |
|
|
SC
67
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
| $5.15M | 0.35% |
+403,657
| New | +$4.9M |
|
68
Amazon
AMZN
$2.87T
| $5.11M | 0.35% |
+105,560
| New | +$5.04M |
|
|
SGYP
69
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| $4.34M | 0.3% |
974,623
-1,263,078
| -56% | -$5.21M |
|
70
Great Elm Group
GEG
$67.7M
| $4.31M | 0.29% |
1,267,205
-1,992
| -0.2% | -$6.71K |
|
71
PUT
Viatris
VTRS
$18.8B
| $3.87M | 0.26% |
+99,800
| New | +$3.83M |
|
72
Fate Therapeutics
FATE
$291M
| $3.73M | 0.25% |
1,150,947
-561,011
| -33% | -$2.15M |
|
|
STDY
73
DELISTED
SteadyMed Ltd
STDY
| $3.17M | 0.22% |
+503,140
| New | +$3.42M |
|
|
ATRS
74
DELISTED
Antares Pharma, Inc.
ATRS
| $3.05M | 0.21% |
946,987
-851,508
| -47% | -$2.41M |
|
|
SGYP
75
CALL
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| $2.89M | 0.2% |
+649,000
| New | +$2.68M |
|
Similar funds
PHP
ACM
FM
PFGIA
PAMI
SI
ZI
RIA
Kingdon Capital Management's Q2 2017 Portfolio in Review
As of Q2 2017, Kingdon Capital Management held 154 positions worth $1.46B, down 20% from $1.82B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Kingdon Capital Management withdrew a net $201M in Q2 2017, closing 58 positions and reducing 33 holdings. Its most notable exit was Adient, an estimated $65M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, down from 32% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Kingdon Capital Management opened a new position in Altaba Inc worth $44.9M.
- Kingdon Capital Management's largest Q2 2017 buy was Altaba Inc: 823,847 shares worth $44.9M.
- Kingdon Capital Management added most to Coca-Cola Europacific Partners in Q2 2017, an estimated $36.6M increase.
- Kingdon Capital Management's biggest Q2 2017 reduction was Comerica, cutting an estimated $29.4M.
- Kingdon Capital Management fully exited Adient in Q2 2017, selling an estimated $65M.
- Kingdon Capital Management's ten largest holdings make up 35% of its $1.46B portfolio in Q2 2017.
- Kingdon Capital Management opened 47 new positions and closed 58 in Q2 2017.
- Kingdon Capital Management's portfolio value fell 20% quarter-over-quarter to $1.46B.
Based on Kingdon Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.